Acetylcysteine for preventing AKI in patients of clinical CKD before angiography: An evidence review

Abstract

CKD has a huge impact on patients, families, and society. Therefore, prevention, treatment and care are more important. Acetylcyctein, an aminolated (acetyl-)-based amino acid (cysteine), is a common antispasmodic drug and is commonly used as a drug to prevent nephrotoxicity caused by a developer. Collect and discuss their effectiveness.

Authors

Wan Ching Tsai
Si Ru Liu
Yang Chi Chen
Yi Ru Wang

Author Details

Wan Ching Tsai, BSN; Si Ru Liu, BSN; Yang Chi Chen, BSN; Yi Ru Wang, BSN; Nursing, Chi Mei Medical Center, Tainan, Taiwan

Sigma Membership

Non-member

Lead Author Affiliation

Chi Mei Medical Center, Tainan, Taiwan

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Acetylcysteine, Angiography, Chronic Kidney Disease

Recommended Citation

Tsai, Wan Ching; Liu, Si Ru; Chen, Yang Chi; and Wang, Yi Ru, "Acetylcysteine for preventing AKI in patients of clinical CKD before angiography: An evidence review" (2019). INRC (Congress). 323.
https://www.sigmarepository.org/inrc/2019/posters_2019/323

Conference Name

30th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Calgary, Alberta, Canada

Conference Year

2019

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Review Type

Abstract Review Only: Reviewed by Event Host

Acquisition

Proxy-submission